These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30091993)

  • 1. Comparison of two different methods of image analysis for the assessment of microglial activation in patients with multiple sclerosis using (R)-[N-methyl-carbon-11]PK11195.
    Kang Y; Schlyer D; Kaunzner UW; Kuceyeski A; Kothari PJ; Gauthier SA
    PLoS One; 2018; 13(8):e0201289. PubMed ID: 30091993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
    Datta G; Colasanti A; Rabiner EA; Gunn RN; Malik O; Ciccarelli O; Nicholas R; Van Vlierberghe E; Van Hecke W; Searle G; Santos-Ribeiro A; Matthews PM
    Brain; 2017 Nov; 140(11):2927-2938. PubMed ID: 29053775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation.
    Kaunzner UW; Kang Y; Monohan E; Kothari PJ; Nealon N; Perumal J; Vartanian T; Kuceyeski A; Vallabhajosula S; Mozley PD; Riley CS; Newman SM; Gauthier SA
    Mult Scler Relat Disord; 2017 Jul; 15():27-33. PubMed ID: 28641769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immune cells and myelin profile in multiple sclerosis: a multi-tracer PET/MR study.
    Pitombeira MS; Koole M; Campanholo KR; Souza AM; Duran FLS; Solla DJF; Mendes MF; Pereira SLA; Rimkus CM; Busatto GF; Callegaro D; Buchpiguel CA; de Paula Faria D
    Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4551-4566. PubMed ID: 35838758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of methods for generating parametric (R-[11C]PK11195 binding images.
    Schuitemaker A; van Berckel BN; Kropholler MA; Kloet RW; Jonker C; Scheltens P; Lammertsma AA; Boellaard R
    J Cereb Blood Flow Metab; 2007 Sep; 27(9):1603-15. PubMed ID: 17311080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased PK11195-PET binding in normal-appearing white matter in clinically isolated syndrome.
    Giannetti P; Politis M; Su P; Turkheimer FE; Malik O; Keihaninejad S; Wu K; Waldman A; Reynolds R; Nicholas R; Piccini P
    Brain; 2015 Jan; 138(Pt 1):110-9. PubMed ID: 25416179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroinflammatory component of gray matter pathology in multiple sclerosis.
    Herranz E; Giannì C; Louapre C; Treaba CA; Govindarajan ST; Ouellette R; Loggia ML; Sloane JA; Madigan N; Izquierdo-Garcia D; Ward N; Mangeat G; Granberg T; Klawiter EC; Catana C; Hooker JM; Taylor N; Ionete C; Kinkel RP; Mainero C
    Ann Neurol; 2016 Nov; 80(5):776-790. PubMed ID: 27686563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simple and rapid quantification of serotonin transporter binding using [
    Gryglewski G; Rischka L; Philippe C; Hahn A; James GM; Klebermass E; Hienert M; Silberbauer L; Vanicek T; Kautzky A; Berroterán-Infante N; Nics L; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Kasper S; Lanzenberger R
    Neuroimage; 2017 Apr; 149():23-32. PubMed ID: 28119137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic comparison of kinetic modelling methods generating parametric maps for [(11)C]-(R)-PK11195.
    Anderson AN; Pavese N; Edison P; Tai YF; Hammers A; Gerhard A; Brooks DJ; Turkheimer FE
    Neuroimage; 2007 May; 36(1):28-37. PubMed ID: 17398120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas.
    Park E; Gallezot JD; Delgadillo A; Liu S; Planeta B; Lin SF; O'Connor KC; Lim K; Lee JY; Chastre A; Chen MK; Seneca N; Leppert D; Huang Y; Carson RE; Pelletier D
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1081-92. PubMed ID: 25833352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions.
    Kaunzner UW; Kang Y; Zhang S; Morris E; Yao Y; Pandya S; Hurtado Rua SM; Park C; Gillen KM; Nguyen TD; Wang Y; Pitt D; Gauthier SA
    Brain; 2019 Jan; 142(1):133-145. PubMed ID: 30561514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglial activation in perinatal rabbit brain induced by intrauterine inflammation: detection with 11C-(R)-PK11195 and small-animal PET.
    Kannan S; Saadani-Makki F; Muzik O; Chakraborty P; Mangner TJ; Janisse J; Romero R; Chugani DC
    J Nucl Med; 2007 Jun; 48(6):946-54. PubMed ID: 17504871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106.
    Takano A; Piehl F; Hillert J; Varrone A; Nag S; Gulyás B; Stenkrona P; Villemagne VL; Rowe CC; Macdonell R; Tawil NA; Kucinski T; Zimmermann T; Schultze-Mosgau M; Thiele A; Hoffmann A; Halldin C
    EJNMMI Res; 2013 Apr; 3(1):30. PubMed ID: 23618062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Test-retest reproducibility of binding parameters in humans with 11C-LY2795050, an antagonist PET radiotracer for the κ opioid receptor.
    Naganawa M; Zheng MQ; Henry S; Nabulsi N; Lin SF; Ropchan J; Labaree D; Najafzadeh S; Kapinos M; Tauscher J; Neumeister A; Carson RE; Huang Y
    J Nucl Med; 2015 Feb; 56(2):243-8. PubMed ID: 25593119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand ¹¹C-PK11195.
    Rissanen E; Tuisku J; Rokka J; Paavilainen T; Parkkola R; Rinne JO; Airas L
    J Nucl Med; 2014 Jun; 55(6):939-44. PubMed ID: 24711650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPM analysis of parametric (R)-[11C]PK11195 binding images: plasma input versus reference tissue parametric methods.
    Schuitemaker A; van Berckel BN; Kropholler MA; Veltman DJ; Scheltens P; Jonker C; Lammertsma AA; Boellaard R
    Neuroimage; 2007 May; 35(4):1473-9. PubMed ID: 17363280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A microPET study of the regional distribution of [11C]-PK11195 binding following temporary focal cerebral ischemia in the rat. Correlation with post mortem mapping of microglia activation.
    Hughes JL; Jones PS; Beech JS; Wang D; Menon DK; Aigbirhio FI; Fryer TD; Baron JC
    Neuroimage; 2012 Feb; 59(3):2007-16. PubMed ID: 22056528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive PK11195-PET Image Analysis Techniques Can Detect Abnormal Cerebral Microglial Activation in Parkinson's Disease.
    Kang Y; Mozley PD; Verma A; Schlyer D; Henchcliffe C; Gauthier SA; Chiao PC; He B; Nikolopoulou A; Logan J; Sullivan JM; Pryor KO; Hesterman J; Kothari PJ; Vallabhajosula S
    J Neuroimaging; 2018 Sep; 28(5):496-505. PubMed ID: 29727504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study.
    Versijpt J; Debruyne JC; Van Laere KJ; De Vos F; Keppens J; Strijckmans K; Achten E; Slegers G; Dierckx RA; Korf J; De Reuck JL
    Mult Scler; 2005 Apr; 11(2):127-34. PubMed ID: 15794383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [¹¹C]-(R)PK11195 tracer kinetics in the brain of glioma patients and a comparison of two referencing approaches.
    Su Z; Herholz K; Gerhard A; Roncaroli F; Du Plessis D; Jackson A; Turkheimer F; Hinz R
    Eur J Nucl Med Mol Imaging; 2013 Sep; 40(9):1406-19. PubMed ID: 23715902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.